Could be good (because it might make the drug QD instead of BID) but may also complicate the development and approval strategy. If this metabolite is not similarly present in their animal tox testing, then they might have to redo some of that testing as if the metabolite was a new drug.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.